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Summary A human breast epithelial cell line (Hu-MI), established by microinjecting SV40 DNA into human
milk epithelial cells, exhibits the phenotype of luminal epithelial cells and is neither clonogenic nor
tumorigenic. From this cell line we have selected two sublines, HuMI-T and HuMI-TTul, reflecting different
stages of spontaneous transformation. HuMI-T cells grow anchorage-independently, but do not induce
tumours in nude mice. HuMI-TTul cells are clonogenic as well as tumorigenic. Cells from both lines exhibit
polymorphic structural and numerical chromosome aberrations. Immortalisation of normal luminal epithelial
cells from human mammary gland with SV40 DNA alone may thus cause random genetic changes eventually
resulting in tumorigenic cell lines. Since Hu-MI, HuMI-T and HuMI-TTul represent some of the consecutive
stages taking place during cellular transformation, they are particularly suited as a novel in vitro model system
to study progression of human breast cancer.
Breast carcinoma ranks high among frequent cancers in
women. Studying growth regulation of normal vs malignant
human mammary epithelial cells (HMEC) and particularly
the process of malignant progression rests on the availability
of systems allowing comparison of tumour cells with the
normal epithelial counterparts from which they were derived.
Many human breast cancer cell lines have been established
(O'Hare, 1991). In contrast, only few HMEC lines from
normal breast cells are available (Paine et al., 1992; Soule et
al., 1990; Briand et al., 1987), most of which, due to the
difficulty of growing breast epithelial cells in culture, have
been spontaneously (Caron de Fromentel et al., 1985) or
selectively established by immortalisation through chemical
agents, viral infection, transfection or microinjection of trans-
forming genes (Berthon et al., 1992; Bartek et al., 1991;
Garcia et al., 1991; Band et al., 1990; Bartek et al., 1990;
Stampfer & Bartley, 1985; Chang et al., 1982). Invasive
breast cancer probably originates from ductal luminal
epithelial cells (Russo et al., 1987; Bartek et al., 1985a;
Wellings et al., 1975). Such 'breast cancer precursor cells' can
be distinguished by their keratin profile and by the expression
of high levels of polymorphic epithelial mucins (Taylor-Papa-
dimitriou et al., 1989; Taylor-Papadimitriou & Lane, 1987;
Bartek et al., 1985b). Differentiated luminal epithelial cells
not contaminated by fibroblasts can be obtained and cultured
from early lactation milk samples (Taylor-Papadimitriou et
al., 1977; Buehring, 1972). This also avoids the risk of co-
culturing contaminating myoepithelial cells (Bartek et al.,
1991; Garcia et al., 1991; Bartek et al., 1990). Indeed, cell
lines established from luminal cells are valuable in vitro tools
to study carcinogenesis of the human mammary gland. Step-
wise analysis of tumour progression would require, however,
a series of cell lines corresponding to the sequence of events
as they occur in vivo.
We report here the establishment of two new sublines,
HuMI-T and HuMI-TTul, from a HMEC line, Hu-MI (Gar-
cia et al., 1991), which was originally obtained by microinjec-
ting SV40 DNA into human milk epithelial cells. HuMI-T
and HuMI-TTul illustrate two different stages of spontan-
eous malignant progression of breast cancer precursor cells.
Since these lines were all derived from normal epithelial cells
of one individual, they may indeed be used as an in vitro
model system and provide new possibilities to study progres-
sion of human breast tumours.
Materials and methods
Cell culture
The Hu-MI cell line has originally been established by SV40-
immortalisation of human mammary epithelial cells cultured
from early lactation samples (Garcia et al., 1991). Hu-MI
cells and their sublines were maintained in RPMI 1640
(Gibco BRL, Gaithersburg, MD) supplemented with 10%
FCS (Seromed, Berlin, Germany). They were incubated at
37°C in a humidified atmosphere containing 5% CO2 in air.
Attached cells were passaged using 0.05% trypsin/EDTA
(Seromed) at a dilution of 1:3 to 1:5 every 3-5 days.
All cell lines were tested periodically for presence of
Mycoplasma using the Myco Tect assay system (Gibco BRL)
and were consistently found to be free of contamination.
Establishment ofsublines
Soft agar assay was used to select anchorage-independent
sublines. Single cell suspensions containing 104 cells in 0.3%
agarose (Sigma, Munich, Germany) were layered onto a
0.5% agarose bottom layer in 100-mm bacteriological Petri
dishes (Greiner, Niirtingen, Germany). Both agarose layers
contained RPMI 1640 supplemented with 10% FCS. Plates
were incubated at 37°C in a humidified atmosphere contain-
ing 5% CO2 in air; fresh medium (0.5 ml) was added to the
plates every 3-4 days. After 4 weeks the cultures were
examined at 60 x magnification using an inverted micro-
scope. Individual colonies of large size located in areas free
of any aggregates were randomly picked up with a micro-
pipet and transferred into 96-well flat-bottomed microtiter
plates (Nunc, Roskilde, Denmark) containing 200 gIl of com-
plete culture medium. After 10- 15 days cultures with adhe-
rent cell growth were trypsinised, transferred into 25-cm2
tissue culture flasks (Tanner, Trasadingen, Switzerland) and
further expanded as described above.
Limiting dilution of cells was used to select sublines from
cultures which were morphologically heterogeneous. Briefly,
200 glI of single cell suspension were plated into 96-well flat-
bottomed microtiter wells at a concentration of 0.7 cells/well.
Growing cultures were expanded as described above.
Doubling time estimation
105cells/well were plated into 24-well tissue culture cluster
plates (Costar, Cambridge, MA) containing RPMI 1640 with
10% FCS. After 24, 48, 72 and 96 h, cells from three wells
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were harvested by trypsinisation, resuspended in culture
medium and counted using a hemocytometer.
Clonogenic assay
Anchorage-independent growth was examined in a
methylcellulose-based assay (Eliason et al., 1985). Cells were
suspended in RPMI 1640 containing 0.9% methylcellulose
(64630, Fluka, Buchs, Switzerland) and 1, 5 or 10% FCS.
Aliquots (1 ml) were plated into 35-mm bacteriological Petri
dishes at a final concentration of 1 x 104 cells/plate. All sam-
ples were set up in triplicate. Cells were incubated for 2
weeks at 37°C in a fully humidified atmosphere of 5% CO2 in
air. Colonies of more than 50 cells were counted using an
inverted microscope.
Tumorigenicity assay
Tumorigenicity of selected Hu-MI cell lines was tested by s.c.
injection of I07 cells into the flank region of 6 to 8 week-old
female nude mice in each experimental group. The animals
were regularly observed for 5 months to detect formation of
tumours.
Immunohistochemistry
The following antigens were identified by means of specific
antibodies: (a) keratins by monoclonal antibodies (MAb)
anti-cytokeratin 18 (CK2) (Boehringer Mannheim) and anti-
cytokeratin 19 (KC19) (Amersham, Aylesbury, UK); (b)
polymorphic epithelial mucins by MAbs to epithelial mem-
brane antigen (EMA) (Amersham) and milk-fat-globule
membrane glycoprotein (MFGM-gp 70) (Imam et al., 1984;
Imam et al., 1981); (c) carcinoembryonic antigen by MAb
CE 25, (kindly provided by Dr J.-P. Mach, Institute of
Biochemistry, Epalinges, Switzerland; (d) large-T viral
antigen by MAb anti-SV40 T antigen (PAb 416) (Oncogene
Science, Uniondale, NY). Cells were grown on glass cover-
slips, rinsed twice with phosphate-buffered saline (PBS),
pH 7.2, fixed in acetone at - 20°C for 10 min and air-dried.
Prior to indirect immunofluorescence staining fixed cells were
rinsed in PBS containing 1% FCS and preincubated with
PBS containing 10% FCS at 37°C for 1 h. Cells were incu-
bated with one of the above listed MAbs for 1 h, washed
with PBS and incubated 1 h with fluorescein isothiocyanate-
conjugated sheep anti-mouse immunoglobulin (Boehringer
Mannheim, Germany). After washing in PBS, stained cells
were mounted in Tris-buffered glycerol and examined micro-
scopically (Polyvar, Reichert-Jung, Vienna, Austria).
For indirect immunoperoxidase studies the peroxidase-
antiperoxidase method was used (Imam & T6kes, 1981;
Taylor, 1978).
Light microscopic examination ofxenograft
Isolated tissue samples were fixed in 2.45% glutaraldehyde
and 1% paraformaldehyde in PBS. They were embedded in
JB-4 plastic (Polysciences, Warrington, PA) and processed;
2p.m-thick sections were stained with Giemsa.
Cytogenetic studies
Confluent cultures of each cell line were blocked in mitotic
metaphase using Colcemid (Fluka, 0.2pgml-') for 75 min
at 37°C. Cells were then dispersed with 0.05% trypsin,
washed in culture medium without FCS, exposed to a hypo-
tonic solution (KCl 0.56%) for 20min at 37°C and fixed
twice in a 1:3 mixture of acetic acid/methanol for 30 and
60min. The cell suspension was finally dropped on wet
slides (water-acetic acid 1:1) and stained for G bands
(Pathak, 1976).
Results
Establishment ofHu-MI sublines and morphology
The Hu-MI mammary cell line has previously been described
as displaying a typical epithelial-like morphology and form-
ing monolayers (Garcia et al., 1991). It has now been kept in
culture for more than 3 years and 140 passages. In one of the
serially transferred batches a crisis event, characterised by
marked decrease in proliferation rate during 2 weeks, took
place around passage 80. Post-crisis Hu-MI cells exhibited
heterogeneous morphology, possibly corresponding to parti-
cular phenotypes that may have emerged during the crisis
period. The appearance of the cell cultures shortly after the
crisis event is illustrated in Figure la. Cultures were com-
posed of two cell types. Epithelial-like cuboidal cells, prob-
ably identical to pre-crisis Hu-MI cells, were engulfed into
islands by a predominant, newly emerged cell type with
rather flattened and elongated morphology. After a few pas-
sages the cultures homogeneously contained such post-crisis
cells, which are referred to as HuMI-T cells (Figure lb).
Since the exact passage number at which HuMI-T cells were
selected could not be determined, we continued to use the
same passage number as for the Hu-MI cells.
In contrast to Hu-MI cells which strictly grow anchorage-
dependently, HuMI-T cells were found to be clonogenic (see
below). In spite of the homogeneous morphology of HuMI-T
cultures, we assumed that they might actually be endowed
with different growth properties. Considering that
clonogenicity correlates best with in vivo tumorigenicity, we
attempted to establish possible tumorigenic sublines of
HuMI-T cells by isolating individual large-sized colonies
growing in soft agar at passage 105. Cells were expanded
and, when heterogeneous morphology was observed, they
were further selected using the limiting dilution technique.
Six sublines were selected (data not shown), three of which
b
Figure 1 Phase contrast photomicrographs illustrating mor-
phology of (a) post-crisis Hu-MI cells at passage 89 and (b)
HuMI-T cells at passage 107. Scale bars: 20 Lm.870 A.YILMAZ etal.
senesced after 4 7 passages. One of the continuous sublines,
HuMI-TTul, was found to be tumorigenic in nude mice (see
below). HuMI-TTul cells were considered to be at passage 1
at the time of selection from soft agar cultures. At early
passages, HuMI-TTul cultures were characterised by mor-
phologically small round-cuboidal cells, together with a few
round and rather large cells (Figure 2a). At later passages
(around passage 20) these large cells had disappeared and
HuMI-TTul cultures consisted of small, rather round-shaped
cells that formed tight monolayers (Figure 2b). Apart from
their epithelial-like aspect they did not morphologically
resemble to either Hu-MI or HuMI-T lines. Establishment of
HuMI-T and HuMI-TTul cells is depicted in Figure 3.
The above mentioned crisis event took place in a batch
which was the only serially transferred culture of Hu-MI cells
in our laboratory at that period. No comparable phen-
omenon was observed to occur again in samples of the same
or other batches of Hu-MI cells placed into long-term cul-
ture. Chromosomal markers common to Hu-MI, HuMI-T
and HuMI-TTul cells (see below), as well as strong and
uniform expression of large T-antigen in all lines (see below)
exclude this 'crisis' event to be related to culture contamina-
tion. DNA fingerprinting of Hu-MI (passage 42), HuMI-T
(passage 118) and HuMI-TTul (passage 18 and 32) has been
performed and has definitely confirmed their common origin.
Grosswth propertie.s
The population doubling time of HuMI-T and HuMI-TTul
cells was 46 and 37 h, respectively. At confluence HuMI-T
and HuMI-TTul cells had a 1.8 or 2.3-fold higher saturation
density than Hu-MI cells, i.e. 2.2 x 105 and 2.8 x 105
cells cm -, respectively.
The parental line Hu-MI does not form colonies in soft
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by SV40 DNA
Crisis stage
(- passage 80)
Selection of individual
colonies of HuMI - T cells
grown in soft agar
Anchorage - dependent,
Hu - Ml nontumorigenic growth
HuMI - T Anchorage - independent,
nontumorigenic growth
Anchorage- independent HuMI - TTu1 tumorigenic growth
Figure 3 Summarised overview of selection and growth proper-
ties of Hu-MI, HuMI-T and HuMI-TTul lines.
agar (Garcia et al., 1991). We repeated clonogenic assays in
methylcellulose and confirmed that their growth remained
indeed strictly anchorage-dependent at early and late pas-
sages, in our laboratory in Epalinges (A. Yilmaz) as well as
in Los Angeles (A. Imam). In contrast, HuMI-T and HuMl-
TTul cells were found to be clonogenic. HuMI-T and HuMI-
TTul cells had maximal cloning efficiencies (C.E.) of 13.7%
and 27.3%, respectively, in methylcellulose supplemented
with 10% FCS. To measure the dependence of anchorage-
independent growth of HuMI-T and HuMI-TTu1 cells on
the concentration of FCS, we performed methylcellulose
assays using 1, 5 and 10% FCS. The C.E. of HuMI-T cells
was not significantly affected by varying FCS concentrations
between 5 and 10% (P= 0.05938) (Figure 4). When com-
pared to C.E. in 10% FCS, colony formation increased by
about 70% in 5% FCS and 100% in 10% FCS. HuMI-TTul
cells, however, were found to be more dependent on high
levels of FCS concentrations, with C.E. increasing by about
190% in 5% FCS (P= 0.0024) and 300% in 10% FCS
(P= 0.0022).
Tumor-igeniciti' and xenografi hiistology,
We tested the tumorigenic potential of HuMI-T and HuMI-
TTul cells by injecting 107 cells of each respective population
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Figure 2 Phase contrast photomicrographs illustrating mor-
phology of (a) HuMI-TTul cells at passage 4 and (b) HuMI-
TTu 1 cells at passage 55. Scale bars: 20 pm.
IF1
LI
10%
FCS concentration
Figure 4 C.E. of HuMI-T (open bars) and HuMI-TTul (filled
bars) in methylcellulose. Values indicate the increase in colony-
formation compared to 1% FCS. Representative for four
experiments.
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s.c. into nude mice. HuMI-T cells were inoculated into five
mice at passage 130 and no tumour growth was observed for
more than 5 months. HuMI-TTul cells were injected at
passage 24 resulting in rapidly growing tumours in 3/4 nude
mice. Tumours tended to ulcerate superficially at 42 days
after inoculation and eventually reached an average volume
of 0.47 cm3 (s.d. = 0.082).
Histological examination of HuMI-TTul cells growing as
s.c. xenografts revealed the presence of a particular pattern
of differentiation. As illustrated in Figure 5, pleomorphic
nuclei and numerous mitotic figures were seen closely
associated with extensions of the murine stroma newly
elicited by tumour cells (St). At distance from such pro-
liferative regions, cells became larger and paler, with distinct
pericellular polygonal irregular borders (*: pavement
appearance). Necrotic areas (N) were found to consist of an
accumulation of dense material together with cellular debris
and pyknotic nuclei, suggestive of keratinocyte-type of
differentiation. No metastatic foci could be detected by his-
tological examination of both regional axillary lymph node
or lung sections.
Two other sublines, which had been selected from indivi-
dual anchorage-independent colonies of HuMI-T cells (see
above) were tested in five nude mice each. They were non-
tumorigenic.
Phenotypic characterisation
The expression of specific epithelial antigens by HuMI-T and
HuMI-TTul cells was determined by immunohistochemistry.
Like the parental line Hu-MI (Garcia et al., 1991), HuMI-T
and HuMI-TTul cells strongly and uniformly expressed
keratin 18 at all passages tested (89 to 125 for HuMI-T and 9
to 49 for HuMI-TTul cells). Expression of keratin 19,
specifically characteristic of mammary epithelial cells of
luminal origin, decreases from 100% in the earliest passage
to 40% at passage 80 of HuMI cells (Garcia et al., 1991).
HuMI-T and HuMI-TTul cells were tested at early and later
passages and were found to be negative for keratin 19 (data
not shown).
Hu-MI, HuMI-T and HuMI-TTul cells have been sub-
jected to immunostaining using antibodies to antigens of
MFGM. Hu-MI (Figure 6a) and HuMI-TTul (Figure 6b)
cells reacted strongly and uniformly with antibodies to
MFGM. HuMI-T cells, however, reacted relatively weakly
with this antibody. All three cell lines were EMA-positive.
Nuclei of Hu-MI, HuMI-T and HuMI-TTul cells were
strongly and uniformly immunoreactive for large-T antigen.
As for Hu-MI cells (Garcia et al., 1991) there was no
immunostaining of HuMI-T and HuMI-TTul cells using an
anti-carcinoembryonic antigen antibody (data not shown).
Figure 5 Histological section of HuMI-TTul cells growing as
s.c. xenograft in nude mice. Scale bar: 100 im.
a
b
Figure 6 Immunoperoxidase staining of (a) Hu-MI cells at pas-
sage 40 and (b) HuMI-TTul cells at passage 20 with anti-MFGM
antibody.
Chromosome analysis
Hu-MI cells were characterised by both structural and
numerical chromosome aberrations at passage 29. The modal
number was 74,X. At least two normal copies of each
chromosome were found, except for a single chromosome X.
Nine markers involving chromosomes 1, 3, 6, 8, 11 and 12
were always present. They can be described as follows: MI:
del(lq), M2: del(lp), M3: del(3p), M4: t(3q;?), M5: t(6p?;12q),
M6: der(8), M7: t(1 lq;?), M8: small isochromosome, Mg:
small acrocentric.
Cytogenetic analysis of HuMI-T cells at passage '.30
revealed two cell populations; 65% of the cells showed a
chromosome number ranging from 59-68, X (3n-), and
35% a total number of 130, XX chromosomes (6n-). At
least one normal copy of each chromosome was present,
except for chromosome 13 which was missing in about 25%
of the analysed cells. Twelve markers were found in at least
60% of the metaphases observed. They involved chromo-
somes 1, 7, 8, 11, 13, 14, 15 and are described as follows: MI:
del(lq), M2: t(lp;7p?), M3: t(lq;15), M4: i(lq), M5: del(7q?),
M6: der(8), M7: i(1llq), M8: 13p+, Mg: 14p+, Mlo: t(15;?),
Ml,: small acrocentric, M12: ring chromosome. MI, M6 and
M9/Ml, are the only common markers of Hu-MI and HuMI-
T cells.
HuMI-TTul cells were analysed at passages 20 (data not
shown) and 45, namely before and after stabilisation of their
morphology. They revealed both structural and numerical
aberrations. At late passage the modal number was 66,XX
with 10% of the cells exhibiting hexaploidy. No normal
copies of chromosomes 1, 3 and 22 were observed. Twenty
markers were identified. Chromosome 1 was involved in the
formation of three markers, resulting in monosomy lp.
Chromosome 3 was involved in the formation of three more
markers resulting in monosomy 3p. Other chromosomes
involved in marker formation were 5, 7, 8, 10, 11 and are
described as follows: M9: t(lp;?), M2: t(lq;?), M3: i(lq), M4:
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der t(lp;3q), M5: t(3q;10q), M6: t(3p;?), M7: der t(5;11), M8:
del(7q), M9: der(8), M1o: lOp-, Ml,: i(llq), M12: t(13;?), M13:
small acrocentric, M14: small isochromosome, M15 to M20
could not be properly ascertained but were constantly found
at both passages analysed. One half of 14 markers which
could be determined at passage 20 were found also at late
passage (MI, M4, M5, M,,, M12, M15, M16) and 13 new
markers had appeared after morphological stabilisation of
HuMI-TTul cells. Markers Mg and M14 were also present in
the parental Hu-MI line. Markers M8, M9, Ml,, M13, and M14
were commonly seen in HuMI-T cells.
Discussion
Cells residing in the terminal ductal lobular units and belong-
ing to the luminal epithelial lineage are the likely precursor
cells of invasive breast cancer. Several mammary epithelial
cell lines have been established by immortalising luminal cells
found in early lactation samples, through introduction of the
SV40 large T-antigen (Garcia et al., 1991; Bartek et al., 1990;
Chang et al., 1982). They retain a phenotype compatible with
the putative role of breast cancer precursor cells and are
neither clonogenic in soft agar nor tumorigenic in nude mice.
The expression of the viral large T-antigen induces con-
tinuous production of growth signals in several cell systems
(Bartek et al., 1991; Lemoine et al., 1989; Poirier et al., 1988)
via binding to a variety of proteins endowed with antipro-
liferative functions, such as the p53 protein (Lane & Craw-
ford, 1979; Linzer & Levine, 1979) and the retinoblastoma
gene product (Huang et al., 1990; Hu et al., 1990). SV40
large T-antigen is capable of transforming cells and causing
tumours in the absence of any cooperating oncogene (Green,
1989; Choi et al., 1983) but SV40-infected normal human
epithelial cells from various tissues have repeatedly been
reported to be non-tumorigenic (Cussenot et al., 1991; Garcia
et al., 1991; Bartek et al., 1990; Chang, 1986) or at best to
grow anchorage-independently (Caron de Fromentel et al.,
1985). Although generally considered to be a rather unlikely
event, malignant transformation of normal cells from mam-
moplasty reduction surgical samples has been observed upon
SV40-immortalisation (Berthon et al., 1992). Our results
indicate that it may also occur in the human luminal mam-
mary epithelial cells. The growth characteristics of HuMI-T
(clonogenic but no tumorigenic growth) and HuMI-TTul
(clonogenic as well as tumorigenic growth) lines further
indicate that the initial immortalisation with SV40 DNA
alone may induce random genetic changes in the host DNA
resulting in differentially transformed cell populations.
Earlier attempts to obtain cell lines from milk cultures by
SV40-immortalisation have resulted in the establishment of
either keratin 19-negative (Caron de Fromentel et al., 1985)
or keratin 19-positive cell lines (Bartek et al., 1990), thus
suggesting that different cell populations had been immor-
talised. Indeed, the proportion of keratin 19-positive Hu-MI
cells already decreases from 100% at early passages to 40%
at passage 80 (Garcia et al., 1991). Finally, both sublines
HuMI-T and HuMI-TTul were keratin 19-negative. Luminal
epithelial cells differentiate from cells located in the basal
layer, keratin 19-negative luminal cells deriving from such
cells are precursors to the 19-positive more differentiated
luminal cells (Bartek et al., 1991). In our sublines, this would
mean that the Hu-MI cell line contained an undetectably
small proportion of keratin 19-negative precursor cells at
early passages which, later on, grew with a selective advan-
tage in culture. On the other hand, such differentiation may
of course be two-directional according to culture conditions.
This is currently being investigated with our cells.
HuMI-T and HuMI-TTul cells were selected following a
period of markedly decreased proliferation rate. This 'crisis'
period, commonly seen with SV40-transformed fibroblasts,
occurred in one culture only and should thus be much rarer
for luminal epithelial cells even though the initial immortalis-
ing agent was the same. Indeed, in a series of SV40-
transformed milk epithelial cells studied by Bartek et al.
(1991) only 5/17 lines underwent a 'crisis' period after which
their growth ceased; these five lines were comprised of elon-
gated cells found in small numbers in milk, likely to originate
from a cell type unrelated to the luminal cell. The events
which have taken place in Hu-MI cells during the 'crisis' stage
are not easily amenable to analysis. An accumulation of
spontaneous chromosomal rearrangements affecting onco-
genes or tumour suppressor genes may have resulted in a
period of instability conferring a selective growth advantage
to newly emerged cell types. Arbitrary and randomly de-
stabilising effects on the mammary cell genome may well be
ascribed to the initial event of immortalisation by SV40 itself.
A correlation between copy number or integration site of
SV40 DNA and induction of distinct growth properties can-
not be ruled out. Hu-MI cells contain two copies of SV40
DNA integrated into the cellular genome and 12-14 copies
of free SV40 DNA (Garcia et al., 1991). Identification of the
number of copies and integration sites of SV40 DNA in our
sublines is under investigation.
Chromosomal alterations are important in the oncogenic
process (Weinberg, 1989; Bishop, 1987). Cytogenetic analyses
of primary and metastatic tumours have outlined genetic
aberrations frequently involving chromosomes 1, 6, 7, 11, 13,
17, and 18 (Cropp et al., 1990; Callahan & Campbell, 1989;
Mackay et al., 1988; Ali et al., 1987; Lundberg et al., 1987).
The relation between a single mutation and the resulting
alteration of growth properties or stage of transformation is
difficult to examine. Interestingly, Hu-MI, HuMI-T and
HuMI-TTul cells all present aberrations of chromosomes 1,
8 and 11, possibly indicative of some intermediate and neces-
sary, but not sufficient steps between normality and malig-
nancy in our model. Whereas a deletion of chromosome 7
was common in HuMI-T and HuMI-TTul cells, aberrations
involving chromosomes 5, 10 and an absence of a normal
chromosome 22 were unique to the tumorigenic cell line
HuMI-TTu1.
No established in vitro cell system allows at present under-
standing all the complexity of mammary tumorigenesis. Most
commonly used breast cancer lines are derived from cells
from pleural effusions; thus, they result from selective pro-
cesses and are not necessarily characteristic of cells in
primary tumours or solid metastases (Dickson & Lippman,
1987). Lines from normal breast tissue, on the other hand,
are established through immortalisation processes or
originate from fibrocystic lesions (Soule et al., 1990; Paine et
al., 1992) and are not truly representative of normal breast
cell behaviour. Though bearing the technically required
disadvantage of being immortalised, Hu-MI, HuMI-T and
HuMI-TTu1 lines, due to their common origin and the
different stages of malignant transformation of breast cancer
precursor cells they represent, may well provide a novel in
vitro system for future comparative studies on growth regula-
tion of breast cells in the process of malignant progression.
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